As president of Veeva Europe, Chris is responsible for growing the business in the region. A 27-year veteran of the life sciences industry, Chris started his career at ICI Pharmaceuticals (now AstraZeneca). Chris then joined a start-up called Kinesis, building a team delivering document management solutions for pharmaceutical companies. Through a series of mergers and acquisitions, Kinesis ultimately became PwC; Chris made partner with PwC in 2001. Chris went on to run both European and US (West Coast) life sciences business for IBM before leading the IBM global life sciences consulting Business Analytics and Optimization unit. Most recently, Chris was the lead partner for life sciences for Europe, the Middle East, and Africa at EY. Chris holds a bachelor of science degree in information technology from the University of Salford.

Matt is co-founder and president of Veeva. Since the company’s launch in 2007, he has helped build Veeva into one of the most valued and trusted partners to the world’s largest pharmaceutical companies and emerging biotechs. With almost 20 years of life sciences expertise, he plays a pivotal role in helping meet customers’ most pressing global requirements in developing and bringing products to market. Prior to starting Veeva, Matt held leadership positions in product management, marketing, and business development at various healthcare technology companies. Earlier in his career, Matt was the general manager of the pharmaceuticals & biotechnology division at Siebel Systems, where he established the company as the market leader in Pharma CRM and clinical trial management systems (CTMS) before its acquisition by Oracle. Matt serves on the board of directors of HealthVerity and advisory board at Crossix, two innovators in healthcare data and analytics. He received an MBA from Harvard Business School and a bachelor of science degree in economics from Yale University.

Jan, our VP, Commercial Strategy, is responsible for strategy of our Veeva Commercial Suite of Applications, focusing on the European market. He has over 20 years’ experience in the software and services industry, mostly dedicated to Pharmaceuticals. Most recently, Jan was leading the Life Sciences Sales & Marketing group in IBM Global Business Services, engaging at strategic level with top 20 Pharmaceutical companies on Customer Relationship Management, Closed Loop Marketing, Multi-Channel and Digital Marketing as well as Digital Asset Management. Prior to IBM, Jan set up and ran the European business for Proscape Technologies, the then leader in Closed Loop Marketing, successfully developing the market from inception, establishing the concept and leading the early implementations. With a BSc in Engineering and an MSc in Business Administration from the University of Twente, in the Netherlands, Jan began his career at Cap Gemini, followed by a move to the UK where he worked with PWC Consulting.

Dr Beau Lotto is a globally renowned neuroscientist whose studies in human perception have taken him well beyond the scientific domain and into the fields of education, the arts and business. Public engagement, in the broadest sense, is at the core of what Beau does – whether he’s creating scientific experiments, giving talks or making TV programmes.